Graphite Bio, Inc. announced earnings results for the quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $17,533,000 against $1,292,000 a year ago. Net loss and comprehensive loss was $17,529,000 against $1,312,000 a year ago. Net loss per share attributable to common stockholders - basic and diluted was $3.45 against $0.56 a year ago. For six months, the company reported loss from operations of $26,901,000 against $1,413,000 a year ago. Net loss and comprehensive loss was $37,238,000 against $1,453,000 a year ago. Net loss per share attributable to common stockholders - basic and diluted was $8.45 against $1.25 a year ago.